The level of induction of NQO1 in the tumours was similar to that observed previously in vitro, and the lack of enzyme induction in the bone marrow was important as marrow toxicity is the dose-limiting toxicity for MMC in the clinic. The gene discussed is NQO1; the disease is neoplasm.